{
    "clinical_study": {
        "@rank": "36980", 
        "arm_group": [
            {
                "arm_group_label": "Sepsis group", 
                "description": "Sixty patients are critically ill with evidence of sepsis during ICU stay (sepsis group) and sixty patients are critically ill without evidence of infectious organism (SIRS group).  At admission, Patients data include clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum level of sTREM-1 and MNDA  will be monitored."
            }, 
            {
                "arm_group_label": "SIRS group", 
                "description": "Sixty  patients are critically ill without evidence of infectious organism (SIRS group).  At admission, Patients data include clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum level of sTREM-1 and MNDA  will be monitored."
            }
        ], 
        "brief_summary": {
            "textblock": "A total of 120 patients will be included in the study. Sixty patients are critically ill\n      with evidence of sepsis during ICU stay (sepsis group) and sixty patients are critically ill\n      without evidence of infectious organism (SIRS group).  At admission, Patients data include\n      clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood\n      gas analysis are measured. Routine cultures will be obtained. The attending physician will\n      evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in\n      ICU. A serum level of sTREM-1 and MNDA  will be monitored."
        }, 
        "brief_title": "Serum STREM and MNDA Mointoring in ICU", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sepsis .", 
        "condition_browse": {
            "mesh_term": "Sepsis"
        }, 
        "detailed_description": {
            "textblock": "A total of 120 patients will be included in the study. Sixty patients are critically ill\n      with evidence of sepsis during ICU stay (sepsis group) and sixty patients are critically ill\n      without evidence of infectious organism (SIRS group).  At admission, Patients data include\n      clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood\n      gas analysis are measured. Routine cultures will be obtained. The attending physician will\n      evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in\n      ICU. A serum level of sTREM-1 and MNDA  will be monitored.\n\n      At admission,  patient's age, sex,  weight and height were  Patients data that  include the\n      clinical status; sequential organ failure assessment (SOFA) score; temperature; heart rate;\n      respiratory rate; blood pressure; central venous pressure; laboratory analysis (complete\n      blood count, blood urea nitrogen, blood sugar, serum sodium, potassium, calcium, aspartate\n      aminotransferase, alanine aminotransferase, prothrombin time, albumin and CRP) and arterial\n      blood gas analysis were measured. Routine cultures of suspected sites, blood and urine were\n      obtained to determine the presence of infection. We attempted to maintain the patient\n      hemoglobin level at 10-12g/dl and central venous pressure at 8-12 cmH2o.  When needed,\n      intravascular fluid replacement,  blood products and inotropic or vasopressor agents were\n      administered. Each day the attending physician evaluated all the study patients for sepsis,\n      severe sepsis, or septic shock as long as their stay in ICU.\n\n      The signs of sepsis were body temperature <36C\u00b0 or > 38C\u00b0, tachycardia (>90 beats/min),\n      ventilatory frequency>20 breath/min or Pco2<32mmHg (unless the patient was mechanically\n      ventilated), a white cell count \u226512\u00d7109 litre-1 or < 4x 109 litre-1, or >10% immature\n      neutrophils, in addition to the presence of infection.  Severe sepsis is a sepsis\n      associated with evidence of organ dysfunction ,  hypoperfusion, acute alteration of mental\n      status, elevated plasma lactate, unexplained metabolic acidosis (arterial ph<7.3),\n      hypoxaemia, prolonged prothrombin time or decrease in platelet count >50% or \u2264100\u00d7109litre1,\n       oliguria and hypotension defined as systolic arterial pressure <90mmHg or a decrease of\n      >40mmHg.  Septic shock was defined as hypotension (<90/60mmHg) in addition to sepsis\n      syndrome persisting despite adequate fluid resuscitation and requiring intropic support"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patients staying in ICU for more than 24 hours will be included in the study.\n\n        Exclusion Criteria:\n\n          -  Patients received anti-inflammatory drugs or corticosteroids before admission,\n             patients had immunosuppressive illness, patients had chronic organ failure; patients\n             received massive blood transfusion; patients with radiation therapy and patients with\n             previous organ transplantation will be excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "120 critically ill patients, sixty patients are critically ill with evidence of sepsis\n        during ICU stay (sepsis group) and sixty patients are critically ill without evidence of\n        infectious organism (SIRS group).  At admission, Patients data include clinical status;\n        SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis\n        are measured. Routine cultures will be obtained. The attending physician will evaluate the\n        patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum\n        level of sTREM-1 and MNDA  will be monitored."
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02120521", 
            "org_study_id": "1637/02/13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Sepsis and SIRS, ICU", 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "contact": {
                "email": "ayman.yousef@rocketmail.com", 
                "last_name": "Ayman A Yousef, MD", 
                "phone": "00201003497767"
            }, 
            "facility": {
                "address": {
                    "city": "Tanta", 
                    "country": "Egypt", 
                    "state": "Algharbyia", 
                    "zip": "35217"
                }, 
                "name": "Tanta University hospitals"
            }, 
            "investigator": {
                "last_name": "Ghada A Suliman, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Predictive Values of Serum STREM and Its Correlation With MNDA Monitoring in Critically Ill Patients.", 
        "overall_contact": {
            "last_name": "Ayman A Yousef, MD", 
            "phone": "002001003497767"
        }, 
        "overall_official": {
            "affiliation": "Assistant Professor", 
            "last_name": "Ayman A Yousef", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "determine the dynamic changes of serum sTREM-1   and the corresponding changes of serum MNDA and their correlation in critically ill sepsis and SIRS patients.", 
            "measure": "dynamic changes of serum sTREM-1  and MNDA", 
            "safety_issue": "Yes", 
            "time_frame": "one week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02120521"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tanta University", 
            "investigator_full_name": "Ayman Abd Al-maksoud Yousef", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "determine the dynamic changes of serum sTREM-1   and the corresponding changes of serum MNDA and their correlation in critically ill sepsis and SIRS patients and survival .", 
            "measure": "Survival in critically ill sepsis and SIRS patients", 
            "safety_issue": "Yes", 
            "time_frame": "two weeks"
        }, 
        "source": "Tanta University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tanta University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}